These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 1591381

  • 1. The critical role of interleukin-6, interleukin-1B and macrophage colony-stimulating factor in the pathogenesis of bone lesions in multiple myeloma.
    Bataille R, Chappard D, Klein B.
    Int J Clin Lab Res; 1992; 21(4):283-7. PubMed ID: 1591381
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms of bone lesions in multiple myeloma and lymphoma.
    Roodman GD.
    Cancer; 1997 Oct 15; 80(8 Suppl):1557-63. PubMed ID: 9362422
    [Abstract] [Full Text] [Related]

  • 3. Update on the pathogenesis of osteolysis in multiple myeloma patients.
    Giuliani N, Colla S, Rizzoli V.
    Acta Biomed; 2004 Dec 15; 75(3):143-52. PubMed ID: 15796087
    [Abstract] [Full Text] [Related]

  • 4. [Bone hyperresorption in multiple myeloma].
    Beaudreuil J, Orcel P.
    Presse Med; 2000 Mar 11; 29(9):492-7. PubMed ID: 10745943
    [Abstract] [Full Text] [Related]

  • 5. The multiple myeloma bone eco-system and its relation to oncogenesis.
    Bataille R.
    Morphologie; 2015 Jun 11; 99(325):31-7. PubMed ID: 26005000
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms of bone lesions in multiple myeloma.
    Bataille R, Chappard D, Klein B.
    Hematol Oncol Clin North Am; 1992 Apr 11; 6(2):285-95. PubMed ID: 1582975
    [Abstract] [Full Text] [Related]

  • 7. The use of clodronate in multiple myeloma.
    Delmas PD.
    Bone; 1991 Apr 11; 12 Suppl 1():S31-4. PubMed ID: 1835398
    [Abstract] [Full Text] [Related]

  • 8. Mechanisms of bone destruction in multiple myeloma.
    Terpos E, Christoulas D, Gavriatopoulou M, Dimopoulos MA.
    Eur J Cancer Care (Engl); 2017 Nov 11; 26(6):. PubMed ID: 28940410
    [Abstract] [Full Text] [Related]

  • 9. Regulation of osteoclast function.
    Suda T, Nakamura I, Jimi E, Takahashi N.
    J Bone Miner Res; 1997 Jun 11; 12(6):869-79. PubMed ID: 9169344
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pathophysiology of multiple myeloma bone disease.
    Lentzsch S, Ehrlich LA, Roodman GD.
    Hematol Oncol Clin North Am; 2007 Dec 11; 21(6):1035-49, viii. PubMed ID: 17996587
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Bone hyperresorption in neoplastic diseases. Foreword].
    Vinceneux P.
    Presse Med; 2000 Mar 11; 29(9):485-6. PubMed ID: 10745941
    [No Abstract] [Full Text] [Related]

  • 16. Macrophage colony-stimulating factor and interleukin-6 release by periprosthetic cells stimulates osteoclast formation and bone resorption.
    Neale SD, Sabokbar A, Howie DW, Murray DW, Athanasou NA.
    J Orthop Res; 1999 Sep 11; 17(5):686-94. PubMed ID: 10569477
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evidence for the secretion of an osteoclast stimulating factor in myeloma.
    Mundy GR, Raisz LG, Cooper RA, Schechter GP, Salmon SE.
    N Engl J Med; 1974 Nov 14; 291(20):1041-6. PubMed ID: 4413338
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.